Vasomotor Symptoms Market

1. Vasomotor Symptoms Market Size, Epidemiology, Emerging Drugs and Key Players What are Vasomotor Symptoms? Vasomotor Symptoms are one of the main symptoms of menopause that principally include hot flashes and night sweats during menopause and occurs in the majority of women across the globe. A woman with Vasomotor Symptoms experiences abundant heat accompanied by sweating and flushing, especially around head, neck, chest, and upper back region. This results from temperature dysfunction that occurs due to changes in gonadal hormones. What was the market size of Hot Flashes associated with Post-Menopause in 2017? The market size of Hot Flashes associated with Post-Menopause in the seven major market was 1,755.8 Million in 2017. What are the Vasomotor Symptoms market drivers? Increasing population of geriatric women, awareness about women hygiene, changes in dietary habits, stress, and focus on hormonal imbalance among women are the Vasomotor Symptoms market drivers. What are the Vasomotor Symptoms market barriers? Generic nature of the market and Limited understanding of Pathophysiology are the Vasomotor Symptoms market barriers. Which companies are developing drugs for Vasomotor Symptoms? KaNDy Therapeutics, Fervent Pharmaceuticals, Astellas Pharma, Sojournix, Mitsubishi Tanabe Pharma are developing drugs for Vasomotor Symptoms treatment market. Request for sample pages for more information on Vasomotor Symptoms forecast- https://www.delveinsight.com/sample-request/vasomotor-symptoms-market